Navigation Links
VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal
Date:12/27/2007

General Meeting vote suggests broad stockholder support for proposed Raven

merger

SOUTH SAN FRANCISCO, Calif., Dec. 27 /PRNewswire-FirstCall/ -- VaxGen Inc. (Pink Sheets: VXGN), a biopharmaceutical company, announced today that its stockholders approved the proposed reverse split of its common stock by a margin of nearly 3 to 1 in favor with approximately 80% of stock voting. The resolution permits VaxGen to reverse split its stock in a ratio of 4, 5, or 6 to 1, at the discretion of the board. The company has previously indicated that it is likely to reverse split the stock 5 to 1.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO)

A similar proportion of stockholders supported the re-election of the Board of Directors.

James P. Panek, VaxGen's CEO and President, commented: "We are very pleased with this result, which seems to indicate a high level of stockholder support for the direction chosen by the company's management and board. With the S-4 registration statement filed just prior to the holidays and Raven and VaxGen agreeing that an OTC Bulletin Board listing satisfies the listing closing condition of the merger agreement, we look forward to a shareholder vote and closure of the merger as expeditiously as possible."

About VaxGen

VaxGen is a biopharmaceutical company based in South San Francisco, California. The company owns a state-of-the-art biopharmaceutical manufacturing facility with a 1,000-liter bioreactor that can be used to make cell culture or microbial biologic products. For more information, please visit the company's web site at http://www.vaxgen.com.

About Raven

Raven biotechnologies, inc. is a privately held biotechnology company focused on the development of monoclonal antibody therapeutics for treating ca
'/>"/>

SOURCE VaxGen Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. VaxGen Files 2006 Financial Statements and Provides Cash Update
2. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
3. VaxGen Files First Quarter 2007 Financials
4. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
5. VaxGen Files Last Outstanding Periodic Report With SEC
6. VaxGen Addresses MPM Claims in Letter to Stockholders
7. VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board
8. ev3 and FoxHollow Announce Date for Special Meeting of FoxHollow Stockholders to Vote on Proposed Merger
9. Micrus Endovascular to Webcast Fiscal 2007 Annual Meeting of Stockholders
10. Kyphon Stockholders Approve Merger with Medtronic
11. Paramount Stockholders Approve Acquisition of Chem Rx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)...   University of Maryland (UM) Ventures and ... of an exclusive option by Biomecite Diagnostics for the ... diagnostics to detect inflammatory bowel diseases (IBD), such as ... Florian Fricke and James White developed ... of Maryland School of Medicine,s Institute for Genome Sciences ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Histogen, ... on the products of cells grown under simulated ... 105F immunomodulatory treatment candidate for melanoma during the ... taking place May 6-9, 2015 in Atlanta, GA. ... cells produce a soluble material with anti-oncologic properties, ...
(Date:5/5/2015)... 5, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: ... for the three months ended March 31, 2015 and ... are in Canadian dollars. Effective July ... from May 31 to December 31. As a result ... is for the three months ended March 31, 2015, ...
(Date:5/5/2015)... DUBLIN , May 05, 2015 /PRNewswire/ ... ) has announced the addition of the ... report to their offering. Macromolecules ... acids undergo separation or are broken into ... biotechnological products. This separation requires various advanced ...
Breaking Biology Technology:Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 3Novel Immunomodulatory Treatment Induces Apoptosis in Melanoma 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 3Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 4Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 5Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 6Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 7Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 8Global Separation Systems Market in Biotechnology 2015-2019 - Trends and Forecasts for the $28 Billion Market 2
... Syndax Pharmaceuticals, Inc. announced today that data ... entinostat, a novel, oral small molecule inhibitor of class ... in patients with relapsed or refractory Hodgkin,s lymphoma (HL).  ... 6:00 to 8:00 PM PT at the American ...
... ICBS Ltd., (OTCPK: ICBT), updates shareholders. As you ... we feel have the greatest chance of success. They are ... each instance, ICBS has funded the purchase of equipment and ... goals. We have paid for all of their expenses in ...
... 2011  CeNeRx BioPharma, Inc., a clinical stage company ... the central nervous system (CNS), today announced completion ... Soros Biopharmaceutical Fund, L Capital Partners, Pappas Ventures ... CeNeRx plans to use the proceeds to complete ...
Cached Biology Technology:Entinostat Demonstrates Activity in Hodgkin's Lymphoma 2Entinostat Demonstrates Activity in Hodgkin's Lymphoma 3Entinostat Demonstrates Activity in Hodgkin's Lymphoma 4Entinostat Demonstrates Activity in Hodgkin's Lymphoma 5ICBS, Update for Shareholders. 2ICBS, Update for Shareholders. 3CeNeRx BioPharma Completes $4.85 Million Financing 2CeNeRx BioPharma Completes $4.85 Million Financing 3
(Date:4/2/2015)... April 2, 2015 In ... by far outperforms the strongest competitors, showing outstanding ... accuracy, the system is capable of a throughput ... proves up to be ten times faster than ... runner-up performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/1/2015)... --  Medisafe ™, the leading global medication management platform ... and Android smartphones and tablets, announces today ... to allow patients to track and correlate their adherence ... will be able to visualize in real-time how taking ... as glucose levels and blood pressure. "Patients ...
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) ... Recognition Market 2015-2019" report to their offering. ... to grow at a CAGR of 23.5 percent over ... present scenario and the growth prospects of the Global ... the market size, the report considers the revenue generated ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... than boys. Every third child of school age prefers soft ... fish and do not think of themselves as being fussy ... taste differently.The findings of the world,s largest study so far ... and what they like have now been published. The study ...
... Society of Japan (PSJ) has chosen Springer to publish ... , starting in January 2009 with Volume 59, Number ... Society and Medical Tribune Co. Ltd. The journal ... includes such publications as Experimental Brain Research ...
... Medical Center have discovered that older people use their ... storing memories, particularly those associated with negative emotions. ... of Psychological Science , is a novel look ... Older adults, average age 70, and younger adults, average ...
Cached Biology News:Girls have superior sense of taste to boys 2Girls have superior sense of taste to boys 3Girls have superior sense of taste to boys 4Springer and the Physiological Society of Japan sign publishing agreement 2Old and young brains rely on different systems to remember emotional content 2
... One-step High Sensitivity Freezing Point Osmometer ... for small volume applications, including pediatric, ... experimental animals. Automatic Calibration with ... Includes built-in printer, keypad and software ...
X-gal,1g...
uncoupling protein 2 (mitochondrial, proton carrier), mRNA (cDNA clone MGC:19567 IMAGE:4335185), complete cds...
RayBio Human Atherosclerosis Antibody Array 1.1 (4) with Accessory, detects 40 inflammatory factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Biology Products: